Longitudinal changes in speech and voice functions after subthalamic stimulation in Parkinson’s disease patients
Objective: To elucidate longitudinal changes of speech and voice functions in Parkinson's disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS). Background: Previously,…Preoperative slowing of EEG and neurocognitive changes following subthalamic nucleus deep brain stimulation in Parkinson’s disease
Objective: We evaluated preoperative electroencephalography (EEG) as predictive markers for changes of neurocognitive functions following subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD). …UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients
Objective: The aim of this study was to evaluate the impact of STN DBS on the changes of UPDRS scale and RS parameters (OFF phase)…Feedback Controlled DBS in Parkinson’s Disease using Electrocorticography
Objective: To provide a proof of principle implementation of closed loop DBS in an office setting using narrowband γ and β power as modulatory signals…Deutetrabenazine Treatment Response by Concomitant Dopamine-Receptor Antagonists in the Phase III, Randomized, Double-Blind, Placebo-Controlled AIM-TD Trial in Tardive Dyskinesia
Objective: To determine the impact of dopamine-receptor antagonist (DRA) use at baseline on the efficacy, safety, and tolerability of deutetrabenazine in patients with tardive dyskinesia…Reversible progressive supranuclear palsy-mimic induced by risperidone
Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal. Background: Drugs that…Characterization of GNB1 mutations as a cause of global developmental delay in combination with dystonia, ataxia, or chorea in children
Objective: To investigate the phenotypic and genotypic spectrum of GNB1 (guanine nucleotide-binding protein, beta 1) mutations and to functionally evaluate their pathogenicity. Background: Global developmental…Huntington’s disease in the Republic of Tatarstan, epidemiological features
Objective: To evaluate the epidemiological features of Huntington's disease (HD) according to the Centre for Movement Disorders and Botulinum Therapy of Republic of Tatarstan (Centre…)…Myths and Misconceptions Regarding Huntington’s Disease in Peru
Objective: To explore the understanding and conceptualization of Huntington’s disease (HD) genetics and pathology among HD patients and family caregivers in Peru. Background: HD is…Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.
Objective: To describe the clinical features and CAG repeats in a large population of Mexican patients with Huntington's disease and its relation to the age…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.